Microvascular Disease

People with type 2 diabetes who spend more time in glycemic range have lower risks for major adverse cardiovascular events, severe hypoglycemia and microvascular events, according to a post hoc analysis of the DEVOTE trial.

PHILADELPHIA — In this Healio video exclusive, Healio | Cardiology Today Editorial Board Member Annabelle Santos Volgman, MD, FACC, FAHA, discusses how microvascular disease raises CVD risk, especially in women and in those with diabetes.

In a prospective cohort study of patients hospitalized with HF with preserved ejection fraction, a majority of participants had evidence of epicardial CAD, coronary microvascular disease or both.

Microvascular angina is a significant health problem that confers risk for major adverse CV events, according to registry data from the Coronary Vasomotor Disorders International Study, or COVADIS, Group.

Adults with type 2 diabetes who have an elevated BMI at diagnosis are at increased risk for microvascular complications, although the risk can be reduced with weight loss, according to a study published in Diabetologia.

The Coronary Vasomotor Disorders International Study Group, which is working to develop standards for diagnosing and treating coronary vasomotor disorders, held its first virtual summit on Sept. 9.

Increasing age at type 2 diabetes diagnosis is associated with progressively lower risks for all-cause mortality, macrovascular and microvascular disease, according to findings from a systematic review of 26 studies.

As an optometrist interested in the evolution of my profession to include more primary health care, I have my Healio email subscriptions and alerts set to receive the Primary Care News Wire. Although I often just skim these articles, I sometimes find an item of interest that has implications for optometry. Such was the case last month when I read, “New diabetes guideline reflects change in glucose therapy considerations.” Published online on Jan. 22, 2020, this article will affect my doctoring of patients with diabetes as well as those at risk for developing the disease.

Adults with latent autoimmune diabetes are 25% more likely to develop microvascular complications beginning in the decade after diagnosis when compared with adults with type 2 diabetes, suggesting that early identification through the measurement of diabetes-related autoantibodies can help reduce risk for adverse outcomes, according to findings from a post hoc analysis published in The Lancet Diabetes & Endocrinology.